1.Plasmakinetic transurethral resection of the prostate: Complications and management thereof
Zonglin WU ; Weijie CHEN ; He GENG
Chinese Journal of Minimally Invasive Surgery 2001;0(05):-
Objective To study the complications and their management of plasmakinetic transurethral resection of the prostate (PKRP). Methods Complications and their management of 51 cases of PKRP from May 2003 to June 2006 were retrospectively reviewed. Results Complications of the procedure were as follows. Bladder spasms occurred in 27 cases (accompanying hemorrhage in 2 cases and urge incontinence in 6 cases), and the symptoms disappeared after patient-controlled intravenous analgesia and M-receptor blocker (tolterodine). Postoperative bleeding occurred in 6 cases. Continuous irrigation with normal saline and medical therapy were given in 3 cases, and open surgery was required in 3 cases with severe bleeding. All bleeding patients obtained a full recovery of voiding function without re-bleeding. Urge incontinence occurred in 13 cases, and was cured with functional exercises of pelvic floor muscles and M-receptor blocker (tolterodine) administration. Stress incontinence was observed in 1 case, and a penile clamp had been used to control incontinence. Among 7 cases of urinary retention after operation, a re-operation of PKRP was conducted in 2 cases and oral medication was carried out in 5. The voiding function recovered well in all the 7 cases. In 5 cases of urethral stricture, urethral dilatation was employed in 3 cases and urethrotomy was performed in 2 cases to obtain a good recovery of voiding function. Conclusions Bladder spasm, postoperative bleeding, incontinence, urinary retention, and urethral stricture are common complications of PKRP. Strict adherence to technique and timely and proper management of complications are considered essential to improve results.
2.The progress in diffusion technologies in the diagnosis of breast cancer
Jie WU ; Cuilan LIU ; Zonglin JING
Practical Oncology Journal 2016;30(6):563-567
In recent years ,the diffusion magnetic resonance imaging in the study of breast cancer is in-creasing,which including diffusion weighted imaging ,diffusion tensor imaging ,intravoxel incoherent motion ,and diffusion kurtosis imaging .The emergence and development of these technologies can be noninvasive quantitative evaluation of breast tumors from the molecular level .The researchers pay more and more attention to the applica-tion of breast cancers diagnosis and differential diagnosis ,therapeutic effect ,prognosis evaluation and so on .This paper reviews the progresses of the above four technologies in the use of the breast cancer .
3.Research advances in MRI features and diagnosis of hepatocellular adenomas
Journal of Clinical Hepatology 2016;32(10):2012-2015
Hepatocellular adenomas (HCA) are rare benign tumors of the liver, and according to the differences in molecular genetics and pathology, HCA is categorized as inflammatory hepatocellular adenoma (IHCA), HCA with hepatocyte nuclear factor 1-alpha mutation (H-HCA), HCA with β-catenin mutation (β-HCA), and an undefined type. The incidence of these four types is 40%-50%, 30%-40%, 10%-15%, and 10%, respectively. In these four types of HCA, β-HCA has high risk of bleeding and malignant transformation, while H-HCA is not likely to show malignant transformation. Therefore, the accurate diagnosis of these types of HCA is very important. This article introduces the radiological features of these types of HCA on conventional MRI and hepatocyte-targeted contrast-enhanced scan and compares these findings with other types of liver solid tumors such as focal nodular hyperplasia, nodular regenerative hyperplasia, liver cancer in non-cirrhotic patients, and fibrolamellar carcinoma of the liver. It is pointed out that MRI and hepatocyte-targeted contrast agents play an important role in the diagnosis and differentiation of HCA.
4.Catheter-Directed Thrombolysis with a Continuous Infusion of Low-Dose Urokinase for Non-Acute Deep Venous Thrombosis of the Lower Extremity.
Binbin GAO ; Jingyong ZHANG ; Xuejun WU ; Zonglin HAN ; Hua ZHOU ; Dianning DONG ; Xing JIN
Korean Journal of Radiology 2011;12(1):97-106
OBJECTIVE: We wanted to evaluate the feasibility of catheter-directed thrombolysis with a continuous infusion of low-dose urokinase for treating non-acute (less than 14 days) deep venous thrombosis of the lower extremity. MATERIALS AND METHODS: The clinical data of 110 patients who were treated by catheter-directed thrombolysis with a continuous infusion of low-dose urokinase for lower extremity deep venous thrombosis was analysed. Adjunctive angioplasty or/and stenting was performed for the residual stenosis. Venous recanalization was graded by pre- and post-treatment venography. Follow-up was performed by clinical evaluation and Doppler ultrasound. RESULTS: A total of 112 limbs with deep venous thrombosis with a mean symptom duration of 22.7 days (range: 15-38 days) were treated with a urokinase infusion (mean: 3.5 million IU) for a mean of 196 hours. After thrombolysis, stent placement was performed in 25 iliac vein lesions and percutaneous angioplasty (PTA) alone was done in five iliac veins. Clinically significant recanalization was achieved in 81% (90 of 112) of the treated limbs; complete recanalization was achieved in 28% (31 of 112) and partial recanalization was achieved in 53% (59 of 112). Minor bleeding occurred in 14 (13%) patients, but none of the patients suffered from major bleeding or symptomatic pulmonary embolism. During follow-up (mean: 15.2 months, range: 3-24 months), the veins were patent in 74 (67%) limbs. Thirty seven limbs (32%) showed progression of the stenosis with luminal narrowing more than 50%, including three with rethrombosis, while one revealed an asymptomatic iliac vein occlusion; 25 limbs (22%) developed mild post-thrombotic syndrome, and none had severe post-thrombotic syndrome. Valvular reflux occurred in 24 (21%) limbs. CONCLUSION: Catheter-directed thrombolysis with a continuous infusion of low-dose urokinase combined with adjunctive iliac vein stenting is safe and effective for removal of the clot burden and for restoration of the venous flow in patients with non-acute lower extremity deep venous thrombosis.
Adult
;
Aged
;
Angioplasty, Balloon
;
*Catheterization, Peripheral
;
Combined Modality Therapy
;
Female
;
Fibrinolytic Agents/*administration & dosage
;
Humans
;
*Infusion Pumps
;
Infusions, Intravenous
;
Leg/*blood supply
;
Male
;
Middle Aged
;
Phlebography
;
*Thrombolytic Therapy/methods
;
Ultrasonography, Doppler
;
Urokinase-Type Plasminogen Activator/*administration & dosage
;
Vascular Patency
;
Venous Thrombosis/*drug therapy/radiography/ultrasonography
5.Treatment of acute renal failure induced by uretericobstruction with Ureteroscope pneumatic litho-tripsy (report of 25 cases)
Hongbing MEI ; Feng WANG ; Jiangping CHANG ; Shaoming ZENG ; Feng WU ; Ming SHI ; Shaobo YE ; Wanhua ZHEN ; Zonglin ZHANG ; Xintao ZHANG ; Jianli CHENG
Journal of Chinese Physician 2010;(z1):36-37
Objective To study the treatment of acute renal failure induced by uretericobstruction . Methods Twenty-five cases of acute renal failure induced by uretericobstruction were emergent managed with ureteroscope pneumatic lithotripsy .Results All the renal function resumed well , BUN,Cr in serum was natural or near natural .Conclusion Ureteroscope pneumatic lithotripsy should be used for acute renal failure induced by uretericobstruction as first-line.